In last trading session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw 0.79 million shares changing hands with its beta currently measuring 1.63. Company’s recent per share price level of $17.82 trading at $0.63 or 3.66% at ring of the bell on the day assigns it a market valuation of $122.56M. That closing price of TNXP’s stock is at a discount of -3671.04% from its 52-week high price of $672.00 and is indicating a premium of 62.07% from its 52-week low price of $6.76. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.59 million shares which gives us an average trading volume of 1.64 million if we extend that period to 3-months.
For Tonix Pharmaceuticals Holding Corp (TNXP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -3.09 in the current quarter.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Upright in the green during last session for gaining 3.66%, in the last five days TNXP remained trading in the green while hitting it’s week-highest on Friday, 04/25/25 when the stock touched $17.82 price level, adding 4.91% to its value on the day. Tonix Pharmaceuticals Holding Corp’s shares saw a change of -45.97% in year-to-date performance and have moved 13.43% in past 5-day. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) showed a performance of -38.04% in past 30-days. Number of shares sold short was 0.92 million shares which calculate 0.39 days to cover the short interests.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
This year revenue growth is estimated to rise 9.97% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 2.55M for the same. And 2 analysts are in estimates of company making revenue of 2.65M in the next quarter. Company posted 2.48M and 2.21M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 46.06% during past 5 years.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Investors also watch the number of corporate investors in a company very closely, which is 2.75% institutions for Tonix Pharmaceuticals Holding Corp that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 10.23 shares of worth $0.18 million or 0.16% of the total outstanding shares. The later fund manager was in possession of 4.02 shares on Feb 28, 2025 , making its stake of worth around $71565.0 in the company or a holder of 0.06% of company’s stock.
